Dudediligence.

Alzamend Neuro, Inc

ALZNNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Reported ·

$448,562

6 sales · 1 buy · $108,388 bought

Oct 2025 to Jun 2026

None of the 6 reported sales carry the 10b5-1 box. Together they are 3.82% of the shares on issue.

REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2025-10-07: AULT MILTON C III, sold2025-10-08: AULT MILTON C III, sold2025-10-23: McGrath Lynne Fahey, sold2025-12-19: Horne William B., sold2025-12-23: AULT MILTON C III, sold2026-04-14: AULT MILTON C III, bought
under a no plan named▼ sale▲ buysize is dollars

Form 4 filings, newest first

2026-04-14AULT MILTON C III$108,388
▲ bought108,388 shno plan namedForm 4 ↗
2025-12-23AULT MILTON C III$3,832
▼ sold1,851 shno plan namedForm 4 ↗
2025-12-19Horne William B.$7,066
▼ sold3,333 shno plan namedForm 4 ↗
2025-10-23McGrath Lynne Fahey$69
▼ sold30 shno plan namedForm 4 ↗
2025-10-08AULT MILTON C III$294,722
▼ sold121,791 shno plan namedForm 4 ↗
2025-10-07AULT MILTON C III$142,874
▼ sold57,379 shno plan namedForm 4 ↗